VYNE Therapeutics Inc. (VYNE)

NASDAQ: VYNE · Real-Time Price · USD

0.5733

+0.0065 (1.15%)

Jan 20, 2026, 10:46 AM EST - Market open

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Chronic Inflammatory and Immune-mediated Therapies	501.00K	Log In	Log In	Log In	Log In	Upgrade
Chronic Inflammatory and Immune-mediated Therapies Growth	18.16%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
United States	501.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	18.16%	Log In	Log In	Log In	Log In	Upgrade